Abacus Life, Inc. (ABL) closed the last trading session at $6.23, gaining 17.1% over the past four weeks, but there could be ...

Abacus Life ( ($ABL) ) just unveiled an update. On November 25, 2025, Abacus Global Management announced the timing of its inaugural annual cash ...

South Korean clinical-stage biotech ABL Bio has entered license, research and collaboration agreement with US pharma major ...

South Korea’s newest billionaire is Lee Sang-hoon, founder of ABL Bio, after it struck a $2.6 billion licensing and joint ...

Eli Lilly invests 22 billion won in ABL Bio to fund Grabody research Lilly to receive 175,079 ABL Bio shares as part of strategic R&D partnership ...

ABL has been awarded a global client relationship agreement (GCRA), an Australian frame agreement and an international frame ...